GSA Capital Partners’s Tectonic Therapeutic TECX Stock Holding History

GSA Capital Partners’s Portfolio TECX Stock Details TECX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$284K	Sell	8,275 -10,598	-56%	-$311K	0.02%	1339
2026 Q1	$583K	Sell	18,873 -44,403	-70%	-$1.09M	0.04%	818
2025 Q4	$1.32M	Buy	+63,276	New	+$1.18M	0.11%	222
2022 Q4	–	Sell	-14,778	Closed	-$114K	–	1960
2022 Q3	$114K	Sell	14,778 -12,745	-46%	-$141K	0.02%	1343
2022 Q2	$304K	Sell	27,523 -679	-2%	-$8K	0.05%	812
2022 Q1	$447K	Buy	28,202 +10,024	+55%	+$207K	0.06%	614
2021 Q4	$840K	Buy	18,178 +2,447	+16%	+$141K	0.11%	291
2021 Q3	$1.05M	Buy	15,731 +9,949	+172%	+$816K	0.11%	291
2021 Q2	$617K	Buy	5,782 +2,812	+95%	+$333K	0.07%	501
2021 Q1	$452K	Buy	2,970 +1,199	+68%	+$195K	0.08%	408
2020 Q4	$296K	Buy	+1,771	New	+$315K	0.05%	744

Other funds holding TECX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

5VM

5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

GSA Capital Partners's TECX Position: Q2 2026 in Review

GSA Capital Partners reduced its Tectonic Therapeutic (TECX) stake by 56% in Q2 2026, selling an estimated $311K and leaving 8,275 shares worth $284K. The position accounts for 0.02% of the portfolio, ranked #1339.

GSA Capital Partners first reported a position in TECX in Q4 2020 and has held it in 11 quarters since. The position peaked at $1.32M in Q4 2025. 122 funds tracked by Wall St. Rank hold TECX as of Q2 2026.

GSA Capital Partners held 8,275 shares of Tectonic Therapeutic worth $284K as of Q2 2026.
GSA Capital Partners sold 10,598 Tectonic Therapeutic shares in Q2 2026, an estimated $311K.
Tectonic Therapeutic made up 0.02% of GSA Capital Partners's portfolio in Q2 2026, its #1339 holding.
GSA Capital Partners first reported a position in Tectonic Therapeutic in Q4 2020 and has held it in 11 quarters since.
GSA Capital Partners's Tectonic Therapeutic position peaked at $1.32M in Q4 2025.
122 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q2 2026.

Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.